TenckhoffH.A., BoenS.T., JebsenR.H., and SpieglerJ.H.: Polyneuropathy in chronic renal insufficiency.JAMA, 192: 1121–1124, 1965.
4.
ThomasP.K., HollinrakeK., LascellesR.G., O'SullivanD.J., BaillodR.A., MoorheadJ.F., and MackenzieJ.C.: The polyneuropathy of chronic renal failure.Brain, 94: 761–780, 1971.
5.
NielsenV. K.: The peripheral nerve function in chronic renal failure.Acta Med. Scand., Suppl.573: 1–32, 1974.
6.
CallaghanN.: Restless legs syndrome in uremic neuropathy.Neurol. (Minneap.), 16: 359–361, 1966.
7.
HardingA.E., and Le FanuJ.: Carpal tunnel syndrome related to antebrachial Cimino-Brescia fistula.J. Neurol. Neurosurg. Phychiat, 40: 511–513, 1977.
8.
DyckP.J., JohnsonW.J., LambertE.H., and O'BrienP.C.: Segmental demyelination secondary to axonal degeneration in uremic neuropathy.Mayo Clin. Proa, 46: 400–431, 1971.
9.
CastaigneP., CathalaH.-P., Beaussart-BoulangéL, and PetroverM.: Effect of ischaemia on peripheral nerve function in patients with chronic renal failure undergoing dialysis treatment.J. Neurol. Neurosurg. Psychiat, 35: 631–637, 1972.
10.
JebsenR.H., TenckhoffH., and HonetJ.C.: Natural history of uremic polyneuropathy and effects of dialysis.N. Eng. J. Med., 277: 327–333, 1967.
11.
Konotey-AhuluF.I.D., BaillodR., ComtyC.M., HeronJ.R., ShaldonS., and ThomasP.K.: Effect of periodic dialysis on the peripheral neuropathy of end-stage renal failure.Br. med. J., 2: 1212–1215, 1965.
12.
BoltonC.F., BaltzanM.A., and BaltzanR.G.: Effects of renal transplantation on uremic neuropathy: a clinical and electrophysiologic study.N. Engl. J. Med., 284: 1170–1175, 1971.
13.
BabbA.L., PopovichR.P., ChristopherT.G., and ScribnerB.H.: The genesis of the square meter-hour hypothesis.Trans. Am. Soc. Art. Int. Org. Trans., 17: 81–91, 1971.
14.
LonerganE.T., SemarM., SterzelR.B., TreserG., NeedleM.A., VoylesL., and LangeK.: Erythrocyte transketolase activity in dialysed patients: a reversible metabolic lesion in uremia.N. Engl. J. Med., 284: 1399–1403, 1971.
15.
De JesusP.V., ClementsR.S., and WinegradA.I.: Hypermyoinositolemic polyneuropathy in rats.J. Neurol. Sci.21: 237–249, 1974.
16.
JefferysJ.G.R., PalmanoK.P., and SharmaA.K.: Influences of dietary myoinositol on nerve conduction and phospholipids in normal and diabetic rats.J. Neurol. Neurosurg. Psychiat., 41: 333–339, 1978.
17.
ReznekR.H., SalwayJ.G., and ThomasP.K.: Plasma-myoinositol levels in uraemic neuropathy.Lancet, 1: 673–676, 1977.
18.
AvramM.M., FeinfeldD.A., and HuatucoA.H.: Search for the uremic toxin: decreased motor-nerve conduction velocity and elevated parathyroid hormone levels in uremia.N. Engl. J. Med.298: 1000–1003, 1978.
19.
LondonG.N., NordmanY., SafarN.E., MetralS., and MillilzP.: Free erythrocyte protoporphyrin level and nerve conduction velocity in end-stage renal failure.Br. med. J.4: 324–325, 1975.
